(Q45771868)

English

Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection

scientific article published in January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

1 reference

based on heuristic

inferred from title

author name string

Kawana T

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

Hashido M

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

Koizumi Y

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

39

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

795-799

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

The Effects of Acyclovir on Antibody Response to Herpes Simplex Virus in Primary Genital Herpetic Infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03272.X

21 January 2018

Identifiers

10.1111/J.1348-0421.1995.TB03272.X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8577270

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45771868&oldid=2082087944"